» Articles » PMID: 22868709

Transplantation: is Donor T-cell Engraftment a Biomarker for Tolerance?

Overview
Journal Nat Rev Nephrol
Specialty Nephrology
Date 2012 Aug 8
PMID 22868709
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Incidental detection of operational tolerance in a deceased donor kidney transplant recipient lost to follow-up for more than 10 years: A case report and literature review.

Roy S, Chowdhury M, Basuli D, Adapa S, Bodziak K Clin Nephrol Case Stud. 2023; 11:12-16.

PMID: 36844261 PMC: 9948746. DOI: 10.5414/CNCS111030.


TCL1A, B Cell Regulation and Tolerance in Renal Transplantation.

Brinas F, Danger R, Brouard S Cells. 2021; 10(6).

PMID: 34206047 PMC: 8230170. DOI: 10.3390/cells10061367.


Operational tolerance in kidney transplantation and associated biomarkers.

Massart A, Ghisdal L, Abramowicz M, Abramowicz D Clin Exp Immunol. 2017; 189(2):138-157.

PMID: 28449211 PMC: 5508347. DOI: 10.1111/cei.12981.


Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance.

Ildstad S, Leventhal J, Wen Y, Yolcu E Chimerism. 2016; 6(1-2):33-9.

PMID: 26745761 PMC: 5063065. DOI: 10.1080/19381956.2015.1130780.


T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.

Pilat N, Farkas A, Mahr B, Schwarz C, Unger L, Hock K J Heart Lung Transplant. 2014; 33(4):429-37.

PMID: 24468120 PMC: 3991417. DOI: 10.1016/j.healun.2013.11.004.


References
1.
Xu H, Chilton P, Huang Y, Schanie C, Yan J, Ildstad S . Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation. Transplantation. 2007; 83(7):954-63. DOI: 10.1097/01.tp.0000258679.18684.b0. View

2.
Ozyurek E, Cowan M, Koerper M, Baxter-Lowe L, Dvorak C, Horn B . Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders. Bone Marrow Transplant. 2008; 42(2):83-91. DOI: 10.1038/bmt.2008.89. View

3.
Niederwieser D, Maris M, Shizuru J, Petersdorf E, Hegenbart U, Sandmaier B . Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can.... Blood. 2002; 101(4):1620-9. DOI: 10.1182/blood-2002-05-1340. View

4.
Ramakrishnan S, Page A, Farris 3rd A, Singh K, Leopardi F, Hamby K . Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am J Transplant. 2012; 12(7):1755-64. PMC: 3387328. DOI: 10.1111/j.1600-6143.2012.04045.x. View

5.
Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud D . Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med. 2012; 4(124):124ra28. PMC: 3610325. DOI: 10.1126/scitranslmed.3003509. View